In recent trading session, Turnstone Biologics Corp (NASDAQ:TSBX) saw 0.43 million shares changing hands at last check today with its beta currently measuring 2.54. Company’s recent per share price level of $0.53 trading at -$0.04 or -6.95% at last check today assigns it a market valuation of $12.26M. That most recent trading price of TSBX’s stock is at a discount of -984.91% from its 52-week high price of $5.75 and is indicating a premium of 16.98% from its 52-week low price of $0.44. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.93 million shares which gives us an average trading volume of 402.85K if we extend that period to 3-months.
For Turnstone Biologics Corp (TSBX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Turnstone Biologics Corp (NASDAQ:TSBX) trade information
Upright in the red during last session for losing -6.95%, in the last five days TSBX remained trading in the green while hitting it’s week-highest on Wednesday, 11/06/24 when the stock touched $0.53 price level, adding 23.93% to its value on the day. Turnstone Biologics Corp’s shares saw a change of -79.16% in year-to-date performance and have moved 11.90% in past 5-day. Turnstone Biologics Corp (NASDAQ:TSBX) showed a performance of 12.28% in past 30-days. Number of shares sold short was 0.39 million shares which calculate 2.82 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 0.5 to the stock, which implies a fall of -6.0% to its recent value today. Analysts have been projecting 0.5 as a low price target for the stock while placing it at a high target of 0.5. It follows that stock’s current price would jump 5.66% in reaching the projected high whereas dropping to the targeted low would mean a gain of 5.66% for stock’s current value.
Turnstone Biologics Corp (TSBX) estimates and forecasts
Statistics highlight that Turnstone Biologics Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -81.52% of value to its shares in past 6 months, showing an annual growth rate of 19.46% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
In 2024, company’s earnings growth rate is likely to be around 26.57% while estimates for its earnings growth in next 5 years are of 17.90%.
